Susan L. McGovern

8.4k total citations · 1 hit paper
127 papers, 5.5k citations indexed

About

Susan L. McGovern is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Surgery. According to data from OpenAlex, Susan L. McGovern has authored 127 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Pulmonary and Respiratory Medicine, 60 papers in Genetics and 20 papers in Surgery. Recurrent topics in Susan L. McGovern's work include Glioma Diagnosis and Treatment (60 papers), Brain Metastases and Treatment (32 papers) and Radiation Therapy and Dosimetry (19 papers). Susan L. McGovern is often cited by papers focused on Glioma Diagnosis and Treatment (60 papers), Brain Metastases and Treatment (32 papers) and Radiation Therapy and Dosimetry (19 papers). Susan L. McGovern collaborates with scholars based in United States, Netherlands and Thailand. Susan L. McGovern's co-authors include Brian K. Shoichet, Emilia Caselli, Nikolaus Grigorieff, Thompson N. Doman, Brian T. Helfand, Brian Y. Feng, John J. Irwin, BinQing Wei, David R. Grosshans and Anita Mahajan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

Susan L. McGovern

114 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening

2002 828 citations Susan L. McGovern, Brian K. Shoichet et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan L. McGovern United States	31	2.3k	1.3k	1.1k	955	791	127	5.5k
Jerry M. Collins United States	52	2.7k 1.2×	1.3k 1.0×	451 0.4×	740 0.8×	713 0.9×	176	9.0k
Léonardo Scapozza Switzerland	43	3.6k 1.6×	381 0.3×	523 0.5×	513 0.5×	461 0.6×	187	7.4k
Bruno O. Villoutreix France	49	3.9k 1.7×	289 0.2×	2.3k 2.0×	596 0.6×	451 0.6×	221	8.5k
Peter Kirkpatrick United States	44	2.7k 1.2×	526 0.4×	409 0.4×	281 0.3×	462 0.6×	146	6.0k
Paul A. Clarke United Kingdom	46	5.1k 2.2×	1.3k 1.0×	442 0.4×	441 0.5×	363 0.5×	139	8.4k
Robert N. Jorissen Australia	21	3.4k 1.5×	758 0.6×	1.3k 1.2×	171 0.2×	1.1k 1.4×	56	6.0k
Gÿorgý Kéri Hungary	41	3.5k 1.5×	482 0.4×	289 0.3×	357 0.4×	349 0.4×	162	6.1k
Matthew M. Ames United States	51	4.0k 1.8×	923 0.7×	224 0.2×	776 0.8×	239 0.3×	239	9.3k
Joel M. Reid United States	51	4.5k 2.0×	1.6k 1.3×	149 0.1×	1.1k 1.1×	961 1.2×	270	10.0k
David R. Newell United Kingdom	49	5.1k 2.2×	1.3k 1.0×	346 0.3×	449 0.5×	356 0.5×	206	10.2k

Countries citing papers authored by Susan L. McGovern

Since Specialization

Citations

This map shows the geographic impact of Susan L. McGovern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan L. McGovern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan L. McGovern more than expected).

Fields of papers citing papers by Susan L. McGovern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan L. McGovern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan L. McGovern. The network helps show where Susan L. McGovern may publish in the future.

Co-authorship network of co-authors of Susan L. McGovern

This figure shows the co-authorship network connecting the top 25 collaborators of Susan L. McGovern. A scholar is included among the top collaborators of Susan L. McGovern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan L. McGovern. Susan L. McGovern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Elyse R., Jennifer S. Haas, Nancy A. Rigotti, et al.. (2025). Integrating Tobacco Treatment Into Lung Cancer Screening. JAMA Internal Medicine. 185(5). 531–531. 4 indexed citations

Flores, Efrén J., Yuchiao Chang, Bianca Porneala, et al.. (2025). Sociodemographic and Health Care Factors Associated With Enrollment in a Randomized Clinical Trial Integrating Tobacco Cessation Into Lung Cancer Screening. Journal of the American College of Radiology. 22(12). 1465–1472.

Matsui, Jennifer K., David L. Swanson, Pamela Allen, et al.. (2025). Reduced Treatment Volumes for Glioblastoma Associated With Lower Rates of Radionecrosis and Lymphopenia: A Pooled Analysis. Advances in Radiation Oncology. 10(3). 101717–101717.

Arrillaga‐Romany, Isabel, Andrew B. Lassman, Susan L. McGovern, et al.. (2024). ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma. Neuro-Oncology. 26(Supplement_2). S173–S181. 25 indexed citations

Bronk, Julianna, Mary Frances McAleer, Susan L. McGovern, et al.. (2024). Comprehensive radiotherapy for pediatric Ewing Sarcoma: Outcomes of a prospective proton study. Radiotherapy and Oncology. 195. 110270–110270. 2 indexed citations

Brown, Austin L., Jack M. Su, M. Fatih Okcu, et al.. (2024). The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma. Neuro-Oncology. 26(10). 1912–1920.

Swanson, T.A., Amol J. Ghia, D.N. Yeboa, et al.. (2023). Early Outcomes from Proton Craniospinal Irradiation (pCSI) for Leptomeningeal Disease from Solid Tumors. International Journal of Radiation Oncology*Biology*Physics. 117(2). e139–e140. 1 indexed citations

Yeboa, D.N., Sujit S. Prabhu, J. Li, et al.. (2023). MD Anderson Phase III Randomized Preoperative Stereotactic Radiosurgery (SRS) vs. Postoperative SRS for Brain Metastases Trial. International Journal of Radiation Oncology*Biology*Physics. 117(2). e160–e161. 2 indexed citations

Arrillaga‐Romany, Isabel, Andrew B. Lassman, Susan L. McGovern, et al.. (2023). P11.46.A ACTION: A RANDOMIZED PHASE 3 STUDY OF DORDAVIPRONE (ONC201) IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA. Neuro-Oncology. 25(Supplement_2). ii84–ii84.

10.

Agarwal, Shreya, Nahir Cortes‐Santiago, Michael E. Scheurer, et al.. (2022). Diffuse alveolar hemorrhage: An underreported complication of transplant associated thrombotic microangiopathy. Bone Marrow Transplantation. 57(6). 889–895. 10 indexed citations

11.

Laperrière, Normand, Vijay Ramaswamy, Éric Bouffet, et al.. (2021). Reevaluating surgery and re-irradiation for locally recurrent pediatric ependymoma—a multi-institutional study. Neuro-Oncology Advances. 3(1). 4 indexed citations

12.

Ludmir, Ethan B., David R. Grosshans, Mary Frances McAleer, et al.. (2021). Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma. International Journal of Radiation Oncology*Biology*Physics. 109(3). 718–725. 7 indexed citations

13.

Yechieli, Raphael, Henry Mandeville, Susan M. Hiniker, et al.. (2021). Rhabdomyosarcoma. Pediatric Blood & Cancer. 68(S2). e28254–e28254. 19 indexed citations

14.

Mahajan, Anita, Peter L. Stavinoha, N. Patrik Brodin, et al.. (2021). Neurocognitive Effects and Necrosis in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. International Journal of Radiation Oncology*Biology*Physics. 119(2). 401–416. 41 indexed citations

15.

Paulino, Arnold C., Kaiping Liao, Susan L. McGovern, et al.. (2020). Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis. Pediatric Blood & Cancer. 67(8). e28373–e28373. 9 indexed citations

16.

Welsh, James W., Ritsuko Komaki, Arya Amini, et al.. (2013). Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 31(7). 895–902. 314 indexed citations

17.

Diehn, Maximilian, Christine Nardini, David S. Wang, et al.. (2008). Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proceedings of the National Academy of Sciences. 105(13). 5213–5218. 345 indexed citations

18.

Sulman, Erik P., Christopher E. Pelloski, J. Matthew McDonald, et al.. (2007). Podoplanin expression is an independent predictor of survival in malignant gliomas. Cancer Research. 67. 2438–2438. 1 indexed citations

19.

McGovern, Susan L., et al.. (2005). The right place in the right space? Awareness of site for needle thoracocentesis. Emergency Medicine Journal. 22(11). 788–789. 53 indexed citations

20.

Irwin, John J., et al.. (2002). Docking and Drug Discovery. TechConnect Briefs. 2(2002). 50–51. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact